A novel topical gel, HT-001, has shown potential as a treatment for cutaneous side effects from epidermal growth factor ...

In patients with cancer, HT-001, designed to address skin toxicities, elicited encouraging interim safety and efficacy ...

Fintel reports that on January 13, 2025, D. Boral Capital initiated coverage of Checkpoint Therapeutics (NasdaqCM:CKPT) with ...

Current treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...

Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar ... DFS compared with placebo for certain patients with cutaneous squamous cell carcinoma, according to the agent ...

The most common reason cited for withdrawal was skin reaction. [37] Rotigotine is a lipophilic dopamine receptor agonist used to treat Parkinson disease. The TTS is applied once daily and worn ...

In milder cases this can be accomplished by relatively simple means: a limited cutaneous rash may be amenable ... through cytoplasmic glucocorticoid receptors. [3] Whether this is clinically ...

A novel topical gel, HT-001, shows promise as a treatment for cutaneous side effects caused by epidermal growth factor receptor inhibitor (EGFRi) cancer therapy. According to a press release ...

Regeneron announces adjuvant Libtayo significantly improves DFS after surgery in high-risk CSCC in phase 3 trial: Tarrytown, New York Wednesday, January 15, 2025, 11:00 Hrs [IST] ...

A team of innovative engineers from Zurich recently unveiled a new haptic sensory system that could revolutionize how people communicate with electronics. For years, electronics have relied on a ...

Chimeric antigen receptor (CAR) T cell therapy directed against cluster of differentiation (CD) 19 is a new promising therapeutic approach in autoimmune diseases. Objectives: To evaluate feasibility ...

Nemluvio (nemolizumab-ilto) Interleukin-31 receptor antagonist Treatment of adults and pediatric patients 12 years of age and older with moderate to severe atopic dermatitis in combination with ...